15 January, 2007 - Ark Therapeutics plc (‘Ark’) today announces that Frost & Sullivan has awarded the 2006 European Product Innovation of the Year Award in the field of Wound Closure to Ark for its efforts in the development and introduction of the novel Kerraboot(R) product. The dual-action Kerraboot(R) helps accelerate chronic wound healing, particularly in the lower limbs.
